These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1874272)

  • 1. Endogenous nitrates--implications for treatment and prevention.
    Anggård EE
    Eur Heart J; 1991 May; 12 Suppl A():5-8. PubMed ID: 1874272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous and exogenous nitrates.
    Anggård EE
    Acta Anaesthesiol Scand Suppl; 1992; 97():7-10. PubMed ID: 1557942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nitric oxide: the endogenous nitrate in the cardiovascular system].
    Tschudi MR; Lüscher TF
    Herz; 1996 Jun; 21 Suppl 1():50-60. PubMed ID: 8767925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelium-derived relaxing factor(s): endogenous nitrates in the circulation?].
    Lüscher TF; Yang Z; Diederich D; Schneider K; von Segesser L; Siebenmann R; Stulz P; Bühler FR
    Schweiz Med Wochenschr; 1988 Nov; 118(46):1724-9. PubMed ID: 3062771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nitric oxide-dependent endogenous and exogenous vasodilators. The mechanism of action of nitrates].
    Machado AP; Alcântara P
    Rev Port Cardiol; 1995 Jan; 14(1):61-71. PubMed ID: 7695956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
    Fasehun OA; Gross SS; Rubin LE; Jaffe EA; Griffith OW; Levi R
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion.
    Lüscher TF; Yang ZH; Diederich D; Bühler FR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S63-9. PubMed ID: 2478827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nitrogen monoxide (NO)--the active principle of organic nitrates].
    Feelisch M
    Schweiz Rundsch Med Prax; 1993 Oct; 82(42):1167-71. PubMed ID: 8248688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances].
    Bassenge E
    Z Kardiol; 1991; 80 Suppl 5():17-21. PubMed ID: 1776330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction and vascular disease.
    Vanhoutte PM
    Verh K Acad Geneeskd Belg; 1998; 60(3):251-66. PubMed ID: 9803882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium-derived relaxing and contracting factors.
    Rubanyi GM
    J Cell Biochem; 1991 May; 46(1):27-36. PubMed ID: 1874796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
    Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nitric oxide and circulatory homeostasis].
    Arnal JF
    Ann Cardiol Angeiol (Paris); 1997; 46(7):420-5. PubMed ID: 9452776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelial dysfunction and atherosclerosis].
    Vanhoutte PM
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():9-19. PubMed ID: 9515109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiology and pathophysiology of nitric oxide.
    Ignarro LJ
    Kidney Int Suppl; 1996 Jun; 55():S2-5. PubMed ID: 8743501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [EDRF-NO. The endothelium-derived relaxing factor is nitric oxide].
    Schreiber V
    Cas Lek Cesk; 1992 Jul; 131(13):388-90. PubMed ID: 1504992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium, coronary vasodilation, and organic nitrates.
    Mehta JL
    Am Heart J; 1995 Feb; 129(2):382-91. PubMed ID: 7832112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier?
    Chirkov YY; Horowitz JD
    Pharmacol Ther; 2007 Nov; 116(2):287-305. PubMed ID: 17765975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.